Infections caused by Stenotrophomonas maltophilia--a prospective study

R Schaumann1, K Stein, C Eckhardt

  • 1Institute for Medical Microbiology and Epidemiology of Infectious Diseases, University of Leipzig, Germany. schaur@medizin.uni-leipzig.de.

Infection
|September 8, 2001
PubMed
Abstract

Insights

Stenotrophomonas maltophilia is increasingly found in hospitals, not just from hospital-acquired infections. Prior carbapenem antibiotic use is not a definitive risk factor for this resistant bacterium.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Hospital Epidemiology

Background:

  • Stenotrophomonas maltophilia is an opportunistic pathogen known for antibiotic resistance.
  • Its isolation from nosocomial infections is increasing.
  • Understanding its epidemiology is crucial for infection control.

Purpose of the Study:

  • To investigate the incidence and characteristics of Stenotrophomonas maltophilia infections in a tertiary care hospital.
  • To identify risk factors associated with S. maltophilia infections.
  • To evaluate the role of prior carbapenem use.

Main Methods:

  • Retrospective analysis of S. maltophilia isolates from 1998-1999.
  • Data collected from 76 patients and 133 specimens.
  • Analysis of patient demographics, specimen sources, and treatment history.

Main Results:

  • S. maltophilia was isolated from 137 specimens (0.26% of all specimens) in 80 patients.
  • Most frequent isolation site was the respiratory tract (54%).
  • Hospital length of stay was an independent risk factor; prior imipenem use was not consistently observed in infected inpatients.

Conclusions:

  • S. maltophilia is not exclusively a nosocomial pathogen.
  • Carbapenem pretreatment is not a reliable indicator for S. maltophilia infection risk.
  • Further research into S. maltophilia epidemiology and resistance mechanisms is warranted.